[RDHL] YoY Annual Result on 31-Dec-2019 [#FY]

Stock
[RDHL] RedHill Biopharma Ltd.
Announcement Date
04-Mar-2020
Financial Year
2019
Quarter
31-Dec-2019 [#FY]
Profit Trend
YoY- -12.40%
Quarter Report
RDHL's Result
RDHL's Financial Summary
View:
Show?
Annual Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 61,800 85,757 64,359 6,291 8,360 4,007 101 191.22%
PBT -71,669 -97,744 -76,173 -42,304 -38,820 -45,544 -29,370 16.02%
Tax -12,424 16,567 12,844 1,330 727 6,285 1,273 -
NP -59,245 -114,311 -89,017 -43,634 -38,820 -45,544 -29,370 12.40%
Tax Rate - - - - - - - -
Total Cost 121,045 200,068 153,376 49,925 47,180 49,551 29,471 26.53%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin -95.87 -133.30 -138.31 -693.59 -464.35 -1,136.61 -29,079.21 -61.40%
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -38.27 -98.27 -97.75 -58.78 -68.00 -104.00 -94.96 -14.04%
EPS Diluted -38.27 -98.27 -97.75 -58.78 -68.00 -104.00 -92.00 -13.59%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.